FDA recall, , Moderate risk
Siemens Healthineers Atellica CH HDL Cholesterol and Total Protein_2 Tests
Atellica CH HDL Cholesterol and Total Protein_2 reagents may cause falsely elevated or depressed test results.
What happened
Siemens Healthcare Diagnostics, Inc. is recalling two test products, Atellica CH Total Protein_2 and Atellica CH HDL Cholesterol. The company says reagent probe carryover may cause falsely elevated or falsely depressed results. Carryover from HDL Cholesterol may cause falsely elevated Hemoglobin A1c results. Carryover from Total Protein_2 may cause falsely depressed Direct Bilirubin 2 results. These results may affect patient samples, quality control, and calibrator results.
The company started the recall on its own and told customers by letter, beginning September 22, 2026. The recall covers 25210 units of Atellica CH Total Protein_2 and 72207 units of Atellica CH HDL Cholesterol. Distribution is nationwide in the United States and worldwide in other countries. The agency classified the recall on November 6, 2026.
What to do
If a code on your device is listed below:
- Check the lot against the recall notice and ask your provider or supplier before you stop using it.
Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.
Is yours affected?
2 products
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
A UDI-DI is the device identifier printed with the barcode on the device label.
Atellica CH Total Protein_2 (TP_2)
Product details from the notice
Atellica CH Total Protein_2 (TP_2);
Siemens Material Number (SMN): 1. 11645755 (3700 tests), 2. 11537228 (7400 tests);- UDI-DI
- 00630414654010
- 00630414611082
- Lot code
- All lots; 2. Siemens Material Number (SMN): 11537228 (7400 tests); UDI-DI: 00630414611082; All lots;
Atellica CH HDL Cholesterol (HDLC)
Product details from the notice
Atellica CH HDL Cholesterol (HDLC);
Siemens Material Number (SMN): 11537213;- UDI-DI
- 00630414610832
- Lot code
- All lots;
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 2, 2026
- Sold in
Distributed nationwide and in Argentina, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Belgium, Bolivia, Brazil, Bulgaria, Burkina Faso, Canada, Chile, China, Colombia, Costa Rica, Croatia, Curaçao, St Eus, Czech Republic, Democratic Republic Congo, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malaysia, Maldives, Mexico, Morocco, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Turkmenistan, U.A.E, Uganda, United Kingdom, Uruguay, Uzbekistan, Vatikancity and Vietnam.
- Recalled by
- Siemens Healthcare Diagnostics, Inc.Tarrytown, New York
- Hazard
- Device defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100035
- Recall numbers
- Z-0364-2027 to Z-0365-2027
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Siemens Healthcare Diagnostics, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Siemens Healthcare Diagnostics, Inc. began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



